Sardocor logo
VerifiedBiotechnology Research

Sardocor

Sardocor, a subsidiary wholly-owned by Medera is dedicated to the clinical development of novel therapies. Building upon Novoheart’s bioengineered human tissue-based assays for disease modelling and drug discovery, Sardocor aspires to create the shortest regulatory path to the clinic for advancing effective next-generation cell & gene therapy

7-day free trial · no credit card

HeadquartersBoston, United StatesEmployees7(11 to 50)Websitemedera.bioLinkedIn profileLinkedIn

Verified contacts

5

available on Kipplo

LinkedIn employees

7

11 to 50 range

Open roles

no listings

Distinct roles

3

indexed titles

Tech stack

1

tools in use

Monthly traffic

organic / mo

Sign up free to see all 5 verified contacts at Sardocor

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

5 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 1 of 5 verified contacts

Top roles at Sardocor

3 distinct titles indexed · top 3 shown.

  • 1financial controller
  • 1senior director of manufacturing
  • 1senior project manager - clinical supply operations cmc

Sign up to unlock all 5 contacts at Sardocor

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 5 verified contacts at Sardocor

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Sardocor | Kipplo Discover